These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3127126)

  • 21. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.
    Anastasiou-Nana MI; Anderson JL; Stewart JR; Crevey BJ; Yanowitz FG; Lutz JR; Johnson TA
    Am Heart J; 1987 May; 113(5):1071-7. PubMed ID: 3107362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic Agent Induced Ventricular Tachycardia.
    Agrawal Y; Kalavakunta JK; Gupta V
    Am J Ther; 2017; 24(4):e487. PubMed ID: 27574940
    [No Abstract]   [Full Text] [Related]  

  • 25. Incessant atrioventricular nodal reciprocating tachycardia successfully treated with intravenous amiodarone.
    Maggioni AP; Volpi A; Cavalli A; Giani P
    Am Heart J; 1985 Jul; 110(1 Pt 1):159-61. PubMed ID: 4013975
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.
    Nicholls DP; Murtagh JG; Holt DW
    Br Heart J; 1985 Apr; 53(4):462-4. PubMed ID: 3986060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide].
    Nitsch J; Köhler U; Neyses L; Lüderitz B
    Z Kardiol; 1988 Feb; 77(2):99-102. PubMed ID: 3129880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
    Haas NA; Fox S; Skinner JR
    Cardiol Young; 2005 Aug; 15(4):427-30. PubMed ID: 16014194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flecainide and amiodarone interaction.
    Shea P; Lal R; Kim SS; Schechtman K; Ruffy R
    J Am Coll Cardiol; 1986 May; 7(5):1127-30. PubMed ID: 3958371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wide complex tachycardia in dialysis patients is not always hyperkalemia.
    Hoang K; Pazderka P; Hakmeh W
    Am J Emerg Med; 2022 Feb; 52():267.e5-267.e7. PubMed ID: 34391584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
    Ergül Y; Özyılmaz İ; Saygı M; Tola HT; Akdeniz C; Tuzcu V
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):607-12. PubMed ID: 26536985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.
    Hong RA; Rivera KK; Jittirat A; Choi JJ
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):794-7. PubMed ID: 22553997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flecainide: a new antiarrhythmic agent.
    Nestico PF; Morganroth J
    Am Fam Physician; 1986 Nov; 34(5):197-200. PubMed ID: 2430440
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.